China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Republican Senators Introduce Bill to Repeal California Vehicle Emissions Waivers
Aug 6, 2026 by
CPI
Mexican Unions Split Over Antitrust Risks in Volaris-Viva Merger
Aug 6, 2026 by
CPI
Nuclear Power Companies Win Early Dismissal of Worker Wage-Fixing Suit
Aug 6, 2026 by
CPI
FCC Vote on TV Ownership Cap Draws Fresh Scrutiny Over Media Consolidation
Aug 6, 2026 by
CPI
Vail, Alterra Face Antitrust Suit Alleging Ski Pass Pricing Scheme
Aug 6, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes